Global Liver Disease Treatment Market to Grow at 6.50% During 2022-2027, Impelled by Increasing Prevalence of Liver Diseases

February 14, 2022

According to the latest report by IMARC Group, titled " Liver Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global liver disease treatment market reached a value of US$ 20.83 Billion in 2021. Liver disease is generally caused due to inherited conditions, infections, misuse of alcohol and obesity. These conditions usually affect and damage the functioning of the liver while causing various chronic conditions, including cancer, cirrhosis and liver failure. Some of its common symptoms include abdominal pain, fatigue, nausea or vomiting, edema and change in the color of stool or urine. Liver disease treatment involves various therapeutic techniques that aid in detoxification, optimizing liver functioning, protecting liver cells from inflammation, improved metabolism and increasing enzyme and bile production. Moreover, early detection and treatment of these conditions help in preventing further damage to the liver while promoting overall liver health.   

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Liver Disease Treatment Market Trends:

The global market is primarily driven by the increasing prevalence of liver diseases among the masses. Coupled with the rising geriatric population that is highly susceptible to developing chronic liver conditions, this is favorably impacting the market growth. Moreover, extensive research and development (R&D) activities conducted in medical science and biotechnology are providing an impetus to the market growth. Furthermore, various technological advancements across the healthcare sector, such as the introduction of gene therapy and bioartificial liver, are positively influencing the market growth. In addition to this, increasing investments and funding to upgrade the existing healthcare infrastructure are considered to be major growth-inducing factors. Apart from this, rapid digitization and the penetration of high-speed internet connectivity and smartphones have enabled easy access to medical facilities for the masses, thereby creating a positive outlook for the market. Other factors, including the changing lifestyle patterns, increasing consumption of alcohol and the rising awareness regarding the harmful effects of liver diseases among the masses, are further contributing to the market growth. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 30.91 Billion by 2027, exhibiting a CAGR of 6.50% during 2022-2027.

Market Summary:

  • On the basis of the treatment type, the market has been segmented into antiviral drugs, immunosuppressants, vaccines, immunoglobulins, corticosteroids, targeted therapy and chemotherapy.
  • Based on the disease type, the market has been segregated into hepatitis, autoimmune diseases, non-alcoholic fatty liver disease (NAFLD), cancer, genetic disorders and others.
  • On the basis of the end-user, the market has been classified into hospitals, ambulatory surgical centers and others.
  • Based on the region, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of the key players are Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Global Liver Disease Treatment Market to Grow at 6.50% During 2022-2027, Impelled by Increasing Prevalence of Liver Diseases
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More